Weight Management: In a retrospective study at Memorial Sloan Kettering Cancer Center (MSKCC), patients with stage 0 to IV breast cancer on GLP-1 RAs for a median of 20 months achieved a mean weight change of 6.2 kg (95% CI, 6.2 to 2.1), which showed a 5% relative weight reduction
Some describe it as improvement
Tirzepatide was used less frequently, with about 12 % of patients starting it for T2DM and 10 % for obesity
This imbalance between apoptosis and regeneration of pancreatic -cells is poorly understood, but several mechanisms have been proposed as triggers for the increased loss [20]
While these medications are incredible tools for metabolic health and weight management, they come with a crucial structural caveat that every patient needs to know
For your safety and optimal results, we require a medical review by our Naturopathic Doctors or a referral from a qualified doctor for IV treatments